CSL (ASX:CSL) to build a new vaccine manufacturing plant

Latest Company News - Finance News Network

English - November 16, 2020 00:00 - 50 seconds - 1000 KB
Business News News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Jumbo Interactive (ASX:JIN) secures first government client

Next Episode: ClearVue Technologies Limited (ASX:CPV) start work on clear solar glass greenhouse

16 Nov 2020 - Global biotechnology leader CSL (ASX:CSL) today announced that Seqirus, a wholly owned subsidiary of CSL, plans to invest more than $800 million in the construction of a new biotech manufacturing facility in Melbourne.